These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 20456739)
41. Factors associated with antihypertensive drug discontinuation among Chinese patients: a cohort study. Wong MC; Jiang JY; Gibbs T; Griffiths SM Am J Hypertens; 2009 Jul; 22(7):802-10. PubMed ID: 19360004 [TBL] [Abstract][Full Text] [Related]
42. The incidence of cancer deaths among hypertensive patients in a large Chinese population: a cohort study. Wong MC; Tam WW; Lao XQ; Wang HH; Kwan MW; Cheung CS; Tong EL; Cheung NT; Griffiths SM; Coats AJ Int J Cardiol; 2015 Jan; 179():178-85. PubMed ID: 25464439 [TBL] [Abstract][Full Text] [Related]
43. Antihypertensive drug class and impaired fasting glucose: a risk association study among Chinese patients with uncomplicated hypertension. Wong MC; Jiang JY; Fung H; Griffiths S; Mercer S BMC Clin Pharmacol; 2008 Sep; 8():6. PubMed ID: 18783618 [TBL] [Abstract][Full Text] [Related]
44. Adherence to combination therapy among ethnic Chinese patients: a cohort study. Wong MC; Jiang JY; Griffiths SM Hypertens Res; 2010 May; 33(5):416-21. PubMed ID: 20111040 [TBL] [Abstract][Full Text] [Related]
45. Comparative effectiveness of antihypertensive drugs in nondiabetic patients with hypertension: A population-based study. Machado MAÁ; de Moura CS; Wang Y; Danieli C; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L J Clin Hypertens (Greenwich); 2017 Oct; 19(10):999-1009. PubMed ID: 28755451 [TBL] [Abstract][Full Text] [Related]
46. Short- and long-term discontinuation patterns of commonly prescribed antihypertensive drugs among a Chinese population: cohort study. Wong MC J Hum Hypertens; 2008 Jun; 22(6):435-7. PubMed ID: 18322547 [TBL] [Abstract][Full Text] [Related]
47. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
48. Antihypertensive drug prescription trends at the primary health care centres in Bahrain. Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335 [TBL] [Abstract][Full Text] [Related]
49. Antihypertensive persistence and drug class. Marentette MA; Gerth WC; Billings DK; Zarnke KB Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422 [TBL] [Abstract][Full Text] [Related]
50. Comparing the cumulative incidences of add-on therapy among the major antihypertensive classes in 2531 Asian patients: a cohort study. Wong MC J Clin Pharm Ther; 2010 Apr; 35(2):201-5. PubMed ID: 20456739 [TBL] [Abstract][Full Text] [Related]
51. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]